BRIEF published on 10/28/2025 at 08:10, 9 months 29 days ago BioCina Appoints Dr. Thomas Broudy as CEO CDMO Drug Development Biopharmaceutical BioCina Dr. Thomas Broudy
PRESS RELEASE published on 10/28/2025 at 08:05, 9 months 29 days ago BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer BioCina appoints Dr. Thomas Broudy as CEO, bringing 20 years of experience in biopharmaceutical industry. The company aims to grow biologic drug substance and sterile drug product services CEO Appointment BioCina Dr. Thomas Broudy Biologic Drug Substance Sterile Drug Product
Published on 08/27/2026 at 00:05, 54 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 1 hour 59 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 2 hours 29 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 2 hours 29 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 3 hours 44 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 1 hour 54 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 6 hours 14 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 6 hours 19 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 6 hours 29 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 6 hours 59 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 6 hours 57 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 6 hours 59 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 7 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 7 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
